These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2168279)

  • 1. Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells.
    Del Bino G; Skierski JS; Darzynkiewicz Z
    Cancer Res; 1990 Sep; 50(18):5746-50. PubMed ID: 2168279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells.
    Traganos F; Ardelt B; Halko N; Bruno S; Darzynkiewicz Z
    Cancer Res; 1992 Nov; 52(22):6200-8. PubMed ID: 1330289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.
    Del Bino G; Darzynkiewicz Z
    Cancer Res; 1991 Feb; 51(4):1165-9. PubMed ID: 1997159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle-related expression of p120 nucleolar antigen in normal human lymphocytes and in cells of HL-60 and MOLT-4 leukemic lines: effects of methotrexate, camptothecin, and teniposide.
    Gorczyca W; Bruno S; Melamed MR; Darzynkiewicz Z
    Cancer Res; 1992 Jun; 52(12):3491-4. PubMed ID: 1596908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells.
    Hotz MA; Del Bino G; Lassota P; Traganos F; Darzynkiewicz Z
    Cancer Res; 1992 Mar; 52(6):1530-5. PubMed ID: 1540962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells.
    Traganos F; Kapuscinski J; Gong J; Ardelt B; Darzynkiewicz RJ; Darzynkiewicz Z
    Cancer Res; 1993 Oct; 53(19):4613-8. PubMed ID: 8402636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of staurosporine on MOLT-4 cell progression through G2 and on cytokinesis.
    Traganos F; Gong J; Ardelt B; Darzynkiewicz Z
    J Cell Physiol; 1994 Mar; 158(3):535-44. PubMed ID: 8126077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different patterns of apoptosis of HL-60 cells induced by cycloheximide and camptothecin.
    Gong J; Li X; Darzynkiewicz Z
    J Cell Physiol; 1993 Nov; 157(2):263-70. PubMed ID: 8227159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4566-76. PubMed ID: 6171341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous analysis of cell cycle kinetics at two different DNA ploidy levels based on DNA content and cyclin B measurements.
    Gong J; Traganos F; Darzynkiewicz Z
    Cancer Res; 1993 Nov; 53(21):5096-9. PubMed ID: 8221643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
    Kaufmann SH
    Cancer Res; 1989 Nov; 49(21):5870-8. PubMed ID: 2790800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis of rat thymocytes triggered by prednisolone, camptothecin, or teniposide is selective to G0 cells and is prevented by inhibitors of proteases.
    Bruno S; Lassota P; Giaretti W; Darzynkiewicz Z
    Oncol Res; 1992; 4(1):29-35. PubMed ID: 1374671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation.
    Del Bino G; Bruno S; Yi PN; Darzynkiewicz Z
    Cell Prolif; 1992 Nov; 25(6):537-48. PubMed ID: 1333822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells.
    Mattern MR; Mong SM; Bartus HF; Mirabelli CK; Crooke ST; Johnson RK
    Cancer Res; 1987 Apr; 47(7):1793-8. PubMed ID: 3028614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of camptothecin on mitogenic stimulation of human lymphocytes: involvement of DNA topoisomerase I in cell transition from G0 to G1 phase of the cell cycle and in DNA replication.
    Bruno S; Giaretti W; Darzynkiewicz Z
    J Cell Physiol; 1992 Jun; 151(3):478-86. PubMed ID: 1338332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
    Bowman KJ; Newell DR; Calvert AH; Curtin NJ
    Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells.
    Goldwasser F; Shimizu T; Jackman J; Hoki Y; O'Connor PM; Kohn KW; Pommier Y
    Cancer Res; 1996 Oct; 56(19):4430-7. PubMed ID: 8813137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of topoisomerase I inhibition on the expression of topoisomerase II alpha measured with fluorescence image cytometry.
    Nicklee T; Crump M; Hedley DW
    Cytometry; 1996 Nov; 25(3):205-10. PubMed ID: 8914817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.
    Hsiang YH; Lihou MG; Liu LF
    Cancer Res; 1989 Sep; 49(18):5077-82. PubMed ID: 2548710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.